N-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)-2-(4-chlorophenoxy)acetamide

ID: ALA4292957

PubChem CID: 145986741

Max Phase: Preclinical

Molecular Formula: C15H14ClN5O3

Molecular Weight: 347.76

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nc2[nH]cc(CNC(=O)COc3ccc(Cl)cc3)c2c(=O)[nH]1

Standard InChI:  InChI=1S/C15H14ClN5O3/c16-9-1-3-10(4-2-9)24-7-11(22)18-5-8-6-19-13-12(8)14(23)21-15(17)20-13/h1-4,6H,5,7H2,(H,18,22)(H4,17,19,20,21,23)

Standard InChI Key:  ZRDKQUDJRWNKIK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   42.3913   -5.2318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.8009   -5.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3934   -6.6472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.7989   -4.5235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3519   -2.6868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3519   -3.5040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.0572   -3.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0572   -2.2741    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.6430   -2.2803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.0572   -4.7257    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.7625   -2.6868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7669   -3.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5422   -3.7477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0169   -3.0868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5349   -2.4312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.6181   -5.9378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0257   -5.2295    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.8429   -5.2283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2486   -5.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.0650   -5.9344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.4734   -5.2256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.0594   -4.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2443   -4.5204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.2906   -5.2233    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  1  4  1  0
  5  6  1  0
  5  8  2  0
  6  7  1  0
  7 12  1  0
 11  8  1  0
  5  9  1  0
  7 10  2  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 13  4  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4292957

    ---

Associated Targets(Human)

LYN Tclin Tyrosine-protein kinase Lyn (4251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.76Molecular Weight (Monoisotopic): 347.0785AlogP: 1.18#Rotatable Bonds: 5
Polar Surface Area: 125.89Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 11.03CX Basic pKa: 4.62CX LogP: 0.73CX LogD: 0.73
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.55Np Likeness Score: -1.17

References

1. Pathania S, Rawal RK..  (2018)  Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.,  157  [PMID:30114661] [10.1016/j.ejmech.2018.08.023]

Source